3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

Can Medical Evidence Be Trusted Without Scrutiny?

Published findings may be affected by methodological issues, reporting choices, and financial interests, highlighting the need for clinicians to carefully assess the evidence.

When to Screen Older Patients for Valve Disease?

Some experts are encouraging patients older than 65 years to get screened for heart valve failure, even as research lags on the benefits of population screening programs.

GLP-1 Therapy and OSA: Promise, But Limits

Tirzepatide improves apnea severity and weight in SURMOUNT-OSA, but experts say many patients still have residual disease and long-term data are needed.

Biomarkers May Help Predict PAP Benefit in Sleep Apnea

Two biomarkers, hypoxic burden and heart rate response, may help identify patients with obstructive sleep apnea who may derive greater cardiovascular benefits from long-term PAP therapy.

Childhood Reasoning Tied to Lower Later-Life Dementia Risk

Higher childhood inductive reasoning ability is associated with a lower risk for dementia decades later.

Tampons Have Traces of Lead: Does it Matter?

While levels of lead released from tampons are low, the amount absorbed into the body and its effects on health are unclear.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

Published findings may be affected by methodological issues, reporting choices, and financial interests, highlighting the need for clinicians to carefully assess the evidence.

Some experts are encouraging patients older than 65 years to get screened for heart valve failure, even as research lags on the benefits of population screening programs.

Tirzepatide improves apnea severity and weight in SURMOUNT-OSA, but experts say many patients still have residual disease and long-term data are needed.

Two biomarkers, hypoxic burden and heart rate response, may help identify patients with obstructive sleep apnea who may derive greater cardiovascular benefits from long-term PAP therapy.

Higher childhood inductive reasoning ability is associated with a lower risk for dementia decades later.

While levels of lead released from tampons are low, the amount absorbed into the body and its effects on health are unclear.

News All Time

The Dark Side of Full Patient Autonomy

Amid the backlash against paternalism and efforts to rebuild trust, an important ethical principle got caught in the fallout: the duty to act in the patient’s best interest.

CDK4/6 Inhibitors: One Class, Three Outcomes

Abemaciclib and ribociclib now show adjuvant survival benefit; palbociclib didn't. Laura Spring, MD, on picking the right agent per patient.

JAK Inhibitors Linked to Reduced Disease Activity in RA

JAK inhibitors are linked to reduced disease activity and improved patient-reported outcomes in patients with rheumatoid arthritis, regardless of diabetes, cardiometabolic burden, or age.

IL-6 May Predict HF Risk in Adults With Obesity and Diabetes

Higher interleukin 6 concentrations are linked to an increased risk for heart failure in adults with type 2 diabetes and overweight or obesity.

Global Definition Breaks MI Into Three Clinical Categories

A new global definition of myocardial infarction will allow cardiologists and other healthcare professionals to improve diagnosis and treatment of patients with the disorder.

‘I Had to Choose’: When Your Medical Career Isn’t Fulfilling

For physicians, a fulfilling career often starts with unlearning the habits that made them successful in medicine — and finding the courage to try.

Normothermia After Cardiac Arrest Tied to Improved Survival

A near-normal peak temperature after in-hospital cardiac arrest is linked to higher survival rates than lower or higher temperature ranges.

Inappropriate Prescribing Cascades Put Older Adults at Risk

Drugs used commonly in older adults can cause side effects that trigger cascades of new prescriptions, potentially causing harm.

High or Low Testosterone May Raise Atrial Fibrillation Risk

A narrative review of the link between testosterone levels and atrial fibrillation in men suggests a U-shaped relationship; however, more research is needed.

Intense Septal LGE on Cardiac MRI Flags Cardiac Amyloidosis

Intense late gadolinium enhancement of the interatrial septum on cardiac MRI offers a highly specific marker to differentiate cardiac amyloidosis from other cardiomyopathies.

Muscle Loss on GLP-1s: Data and Debate

Muscle loss during GLP-1 therapy sparked a lively debate at the 2026 ADA Scientific Sessions. Here's what the data show, who's at risk, and how to counsel patients.

Where You Live May Shape Sleep Apnea Outcomes

Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events.

CGM Looks Perfect. A1c Doesn't. Which One Is Right?

CGM and A1c increasingly disagree, especially with AID pumps. When should clinicians trust time in range over A1c? The evidence, the guideline gaps, and access disparities in type 1 and 2 diabetes.

Stroke Risk Peaks in the 3 Months After Cancer Diagnosis

The magnitude of the risk varies widely by cancer type, being highest for patients with lung or pancreatic cancers.

Routine Liver Markers May Signal Future Cardiovascular Risk

Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline.

Functional Angio Wins in Multivessel STEMI

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.

Recommended News For You

Approved BTK Inhibitor Without Covalent Bond for CLL.

The New Perfectionism Problem in Medical Training

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Short-course radiation matches standard therapy for endometrial cancer

Children living near oil and gas wells face higher risk of rare leukemia, studies show

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Recommended Articles For You

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

Exploring The Causes and Consequences of Low Transferrin Saturation 

The Miracle of Tenecteplase: How This Drug Is Saving Lives 

Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

2.

For treatment, the majority of cancer patients choose complementary therapies.

3.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

4.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

1.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

2.

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes

3.

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology

4.

Exploring the Latest Treatments for Desmoid Tumors

5.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

2.

How Blood Tests Help Detect Hematological Disorders

3.

How Cancer Screening Supports Early Diagnosis

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot